overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Surgical Intervention

InterStim Therapy
  • Used in patients with urinary urgency, frequency, urge incontinence and retention
  • A small device implanted under the skin of one of the upper buttocks
  • Works by gently stimulating the sacral nerves to help the bladder function normally
Augmentation Cystoplasty
  • Small piece of tissue from the intestine is added to the wall of the bladder to increase the size of the bladder
  • Done by opening the abdomen and sometimes through the use of laparoscope
  • Consider in patients with non-progressive neurological disorders and impaired bladder storage
Urinary Diversion
  • Procedure is only done if all other options have failed to treat overactive bladder (OAB) symptoms
  • Tubes from the kidneys to the bladder and ureters are routed directly to the outside of your body
Nerve Stimulation
Sacral nerve stimulation
  • Small pulse generator is implanted under the skin of the buttock to send electrical signals to the nerves that control the bladder
Peroneal nerve stimulation
  • Another pulse generator used to stimulate the nerves controlling the bladder
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.
Stephen Padilla, 3 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.